InvestorsHub Logo
Followers 0
Posts 56
Boards Moderated 0
Alias Born 08/02/2021

Re: None

Thursday, 06/30/2022 7:12:43 AM

Thursday, June 30, 2022 7:12:43 AM

Post# of 44784
"We also plan to release topline results from our multinational Phase III study for muscle regeneration following hip fracture surgery during the third calendar quarter of 2022."- Pluristem CEO back in march. Good PSTO news coming soon?